158 related articles for article (PubMed ID: 23846805)
1. Continuous inhibition of poly(ADP-ribose) polymerase does not reduce reperfusion injury in isolated rat heart.
Nishizawa K; Yanagida S; Yamagishi T; Takayama E; Bessho M; Kusuhara M; Adachi T; Ohsuzu F
J Cardiovasc Pharmacol; 2013 Jul; 62(1):99-105. PubMed ID: 23846805
[TBL] [Abstract][Full Text] [Related]
2. Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model.
Yamazaki K; Miwa S; Ueda K; Tanaka S; Toyokuni S; Unimonh O; Nishimura K; Komeda M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):270-5. PubMed ID: 15296882
[TBL] [Abstract][Full Text] [Related]
3. Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment.
Zhang LQ; Qi GX; Jiang DM; Tian W; Zou JL
Shock; 2012 May; 37(5):492-500. PubMed ID: 22266967
[TBL] [Abstract][Full Text] [Related]
4. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of caspase-9 and poly(ADP-ribose) polymerase inhibitors on ischemia-reperfusion-induced myocardial injury.
Sodhi RK; Singh M; Singh N; Jaggi AS
Arch Pharm Res; 2009 Jul; 32(7):1037-43. PubMed ID: 19641885
[TBL] [Abstract][Full Text] [Related]
6. Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences.
Liaudet L; Szabó E ; Timashpolsky L; Virág L; Cziráki A; Szabó C
Br J Pharmacol; 2001 Aug; 133(8):1424-30. PubMed ID: 11498530
[TBL] [Abstract][Full Text] [Related]
7. Post-treatment at 12 or 18 hours with 3-aminobenzamide ameliorates retinal ischemia-reperfusion damage.
Chiang SK; Lam TT
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3210-4. PubMed ID: 10967085
[TBL] [Abstract][Full Text] [Related]
8. Effects of 3-aminobenzamide on expressions of poly (ADP ribose) polymerase and apoptosis inducing factor in cardiomyocytes of rats with acute myocardial infarction.
Zhao YJ; Wang JH; Fu B; Ma MX; Li BX; Huang Q; Yang BF
Chin Med J (Engl); 2009 Jun; 122(11):1322-7. PubMed ID: 19567145
[TBL] [Abstract][Full Text] [Related]
9. The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts.
Pálfi A; Tóth A; Kulcsár G; Hantó K; Deres P; Bartha E; Halmosi R; Szabados E; Czopf L; Kálai T; Hideg K; Sümegi B; Tóth K
J Pharmacol Exp Ther; 2005 Oct; 315(1):273-82. PubMed ID: 15951400
[TBL] [Abstract][Full Text] [Related]
10. The effect of 3-aminobenzamide, an inhibitor of poly-ADP-ribose polymerase, on ischemia/reperfusion damage in rat retina.
Lam TT
Res Commun Mol Pathol Pharmacol; 1997 Mar; 95(3):241-52. PubMed ID: 9144832
[TBL] [Abstract][Full Text] [Related]
11. The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals.
Koh SH; Park Y; Song CW; Kim JG; Kim K; Kim J; Kim MH; Lee SR; Kim DW; Yu HJ; Chang DI; Hwang SJ; Kim SH
Eur J Neurosci; 2004 Sep; 20(6):1461-72. PubMed ID: 15355313
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass.
Khan TA; Ruel M; Bianchi C; Voisine P; Komjáti K; Szabo C; Sellke FW
J Am Coll Surg; 2003 Aug; 197(2):270-7. PubMed ID: 12892811
[TBL] [Abstract][Full Text] [Related]
13. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-ribose) polymerase activation in the reperfused myocardium.
Szabó G; Liaudet L; Hagl S; Szabó C
Cardiovasc Res; 2004 Feb; 61(3):471-80. PubMed ID: 14962478
[TBL] [Abstract][Full Text] [Related]
15. [Neuronal death: potential role of the nuclear enzyme, poly (ADP-ribose) polymerase].
Boulu RG; Mesenge C; Charriaut-Marlangue C; Verrecchia C; Plotkine M
Bull Acad Natl Med; 2001; 185(3):555-63; discussion 564-5. PubMed ID: 11501263
[TBL] [Abstract][Full Text] [Related]
16. Activation of poly(ADP-ribose) polymerase in circulating leukocytes during myocardial infarction.
Murthy KG; Xiao CY; Mabley JG; Chen M; Szabó C
Shock; 2004 Mar; 21(3):230-4. PubMed ID: 14770035
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of poly (ADP-ribose) polymerase inhibition against the reperfusion injury in heart transplantation.
Fiorillo C; Ponziani V; Giannini L; Cecchi C; Celli A; Nediani C; Perna AM; Liguori P; Nassi N; Formigli L; Tani A; Nassi P
Free Radic Res; 2003 Mar; 37(3):331-9. PubMed ID: 12688429
[TBL] [Abstract][Full Text] [Related]
18. An inhibitor of poly (ADP-ribose) synthetase activity reduces contractile dysfunction and preserves high energy phosphate levels during reperfusion of the ischaemic rat heart.
Docherty JC; Kuzio B; Silvester JA; Bowes J; Thiemermann C
Br J Pharmacol; 1999 Jul; 127(6):1518-24. PubMed ID: 10455304
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Muià C; Patel NS; Threadgill MD; Bramanti P; De Sarro A; Thiemermann C; Cuzzocrea S
J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194
[TBL] [Abstract][Full Text] [Related]
20. Inhibitors of poly (ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration.
Kaplan J; O'Connor M; Hake PW; Zingarelli B
Shock; 2005 Mar; 23(3):233-8. PubMed ID: 15718920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
